At the LMS, my research uses Caenorhabditis elegans as a model to uncover potential therapeutic compounds through bacterial bioactivity. With access to cutting-edge equipment and a collaborative environment, I focus on screening and identifying bioactive compounds that could lead to innovative treatments for challenging human diseases. Additionally, I am exploring the sensory mechanisms of C. elegans, to better understand their roles in behaviour and disease. My work also extends into neurodegenerative disease research, using C. elegans as a model to study the pathways involved in these conditions, aiming to provide insights into potential therapeutic interventions.